Hepatic Mitochondrial Function Analysis Using Needle Liver Biopsy Samples
Open Access
- 29 October 2013
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 8 (10), e79097
- https://doi.org/10.1371/journal.pone.0079097
Abstract
Current assessment of pre-operative liver function relies upon biochemical blood tests and histology but these only indirectly measure liver function. Mitochondrial function (MF) analysis allows direct measurement of cellular metabolic function and may provide an additional index of hepatic health. Conventional MF analysis requires substantial tissue samples (>100 mg) obtained at open surgery. Here we report a method to assess MF using <3 mg of tissue obtained by a Tru-cut® biopsy needle making it suitable for percutaneous application. An 18G Bard® Max-core® biopsy instrument was used to collect samples. The optimal Tru-cut® sample weight, stability in ice-cold University of Wisconsin solution, reproducibility and protocol utility was initially evaluated in Wistar rat livers then confirmed in human samples. MF was measured in saponin-permeabilized samples using high-resolution respirometry. The average mass of a single rat and human liver Tru-cut® biopsy was 5.60±0.30 and 5.16±0.15 mg, respectively (mean; standard error of mean). Two milligram of sample was found the lowest feasible mass for the MF assay. Tissue MF declined after 1 hour of cold storage. Six replicate measurements within rats and humans (n = 6 each) showed low coefficient of variation (<10%) in measurements of State-III respiration, electron transport chain (ETC) capacity and respiratory control ratio (RCR). Ischemic rat and human liver samples consistently showed lower State-III respiration, ETC capacity and RCR, compared to normal perfused liver samples. Consistent measurement of liver MF and detection of derangement in a disease state was successfully demonstrated using less than half the tissue from a single Tru-cut® biopsy. Using this technique outpatient assessment of liver MF is now feasible, providing a new assay for the evaluation of hepatic function.Keywords
This publication has 13 references indexed in Scilit:
- The Current State of Knowledge of Hepatic Ischemia-Reperfusion Injury Based on Its Study in Experimental ModelsJournal of Biomedicine and Biotechnology, 2012
- Clinical Review of Nonalcoholic Steatohepatitis in Liver Surgery and TransplantationJournal of the American College of Surgeons, 2010
- Histopathology of nonalcoholic fatty liver diseaseWorld Journal of Gastroenterology, 2010
- Assessment of Hepatic Steatosis by Expert PathologistsAnnals of Surgery, 2009
- A systematic review of experimental treatments for mitochondrial dysfunction in sepsis and multiple organ dysfunction syndromeFree Radical Biology & Medicine, 2009
- Clinical Laboratory Tests: Which, Why, and What Do The Results Mean?Laboratory Medicine, 2009
- Analysis of mitochondrial function in situ in permeabilized muscle fibers, tissues and cellsNature Protocols, 2008
- Polarographic Oxygen Sensors, the Oxygraph, and High‐Resolution Respirometry to Assess Mitochondrial FunctionPublished by Wiley ,2008
- Mitochondria in health and disease: perspectives on a new mitochondrial biologyMolecular Aspects of Medicine, 2004
- Impairment of mitochondrial oxidative phosphorylation in rat fatty liver exposed to preservation-reperfusion injuryJournal of Hepatology, 2004